Login

Healthcare

00:10:00
Thomas Hanly Discusses Singular Health’s Growth and Vision in Interactive Q&A with Investors | Thomas Hanly, CEO , Singular Health Group Ltd.
00:10:00
Lars Minor on Newbury Pharmaceuticals’ Vision and Strategy | Lars Minor, CEO , Polymetals Resources Ltd.
00:10:00
CEO Thomas Hanly Reflects on His 30-Year Journey and Singular Health’s Path Forward | Thomas Hanly, CEO , Singular Health Group Ltd.
00:10:00
Innovative Volume Rendering Solutions by Singular Health: Transforming Medical Imaging | Thomas Hanly, CEO , Singular Health Group Ltd.
00:10:00
James Hill Discusses Singular Health’s Vertically Integrated Medical Business | James Hill, COO , Singular Health Group Ltd.
00:10:00
Innovating Pharma: Lars Minor Discusses Newbury’s Product Rollout Plans | Lars Minor, CEO , Polymetals Resources Ltd.
00:10:00
3D Medical Imaging: Revolutionizing Healthcare with Singular Health Group Ltd | Thomas Hanly, CEO , Singular Health Group Ltd.
00:10:00
Exploring Hubbster's SaaS Platform and Newbury's Pharmaceutical Growth | Lars Minor, CEO , Polymetals Resources Ltd.
00:10:00
James' Vision for Bridge Biotherapeutics: Advancing Pulmonary Fibrosis, Lung Cancer, and Immunology Treatments| James Lee, CEO , Bridge Biotherapeutics Inc.
00:10:00
Jeong-gyu Lee Shares Insights on Drug Development and Startup Success | James Lee, CEO , Bridge Biotherapeutics Inc.
00:10:00
CEO Spotlight: Benjamin Lightburn on Filament Health's Mission and Milestones | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
Ben Lightburn Discusses Filament Health's Mission to Standardize Natural Psychedelics | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
Pioneering Safe and Accessible Natural Psychedelics for Healing | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
Kancera CEO Thomas Olin Discusses Kand567 Phase 2 Studies for COVID-19 and Acute Myocardial Infarction | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Philogen CEO Dario Neri Introduces the Company to the City | Dario Neri, CEO ,Philogen spa.
00:10:00
Exploring Demoralization Syndrome Treatment with Filament Health’s Psilocybin Trials | Benjamin Lightburn, CEO , Filament Health Corp.

© 2017 - Townhall + Tv